Thousands of patients are transitioning to new monitoring devices that can track their diabetes and wirelessly send glucose readings to another device for regular updates, the AP/Ventura County Star reports.
Federal health officials over the last six months approved children's use of the sensor, which is implanted under the skin for three consecutive days, and a seven-day model for adults, the longest use period that FDA so far has approved.
Some short-term studies have found that users can improve the control of their blood sugar through the devices, although other studies have found minimal impact. Irl Hirsch of the University of Washington said the discrepancy can be attributed to a lack of effort from diabetics, not the sensor technology.
The glucose sensors can cost up to $1,000, with at least $350 in monthly fees for supplies. Although some insurers pay for them, many refuse to reimburse patients for the devices until there is more proof that they improve health, the AP/Star reports.
Sensors currently available are Medtronic's three-day Real-Time monitor for adults and children, and DexCom's STS-7 seven-day model for adults. Abbott Laboratories is developing a five-day model (Neergaard, AP/Ventura County Star, 9/19).